Kengo Furuichi

Author PubWeight™ 43.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol 2004 1.97
2 Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol 2012 1.95
3 Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice. Cancer Res 2009 1.51
4 Pathologic findings of initial biopsies reflect the outcomes of membranous nephropathy. Kidney Int 2004 1.46
5 Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis. J Am Soc Nephrol 2004 1.44
6 Immunomodulation effects and clinical evidence of apheresis in renal diseases. Ther Apher Dial 2003 1.39
7 MCP-1/CCR2-dependent loop for fibrogenesis in human peripheral CD14-positive monocytes. J Leukoc Biol 2006 1.22
8 Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes. Clin Exp Nephrol 2013 1.20
9 Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy. Am J Kidney Dis 2005 1.19
10 p38 Mitogen-activated protein kinase contributes to autoimmune renal injury in MRL-Fas lpr mice. J Am Soc Nephrol 2003 1.04
11 The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese. Kidney Int 2004 1.01
12 Involvement of CD11b+ GR-1 low cells in autoimmune disorder in MRL-Fas lpr mouse. Clin Exp Nephrol 2010 0.99
13 p38 MAPK phosphorylation and NF-kappa B activation in human crescentic glomerulonephritis. Nephrol Dial Transplant 2002 0.95
14 Involvement of bone-marrow-derived cells in kidney fibrosis. Clin Exp Nephrol 2010 0.95
15 Fibrocytes are involved in the pathogenesis of human chronic kidney disease. Hum Pathol 2009 0.95
16 Adipose tissue-derived stem cells as a regenerative therapy for a mouse steatohepatitis-induced cirrhosis model. Hepatology 2013 0.92
17 Activation of p38 mitogen-activated protein kinase promotes peritoneal fibrosis by regulating fibrocytes. Perit Dial Int 2011 0.92
18 Combined pure red cell aplasia and autoimmune hemolytic anemia in systemic lupus erythematosus with anti-erythropoietin autoantibodies. Am J Hematol 2008 0.91
19 The role of cytokine in the lupus nephritis. J Biomed Biotechnol 2011 0.90
20 Three cases of pneumatosis intestinalis presenting in autoimmune diseases. Mod Rheumatol 2011 0.90
21 Blockade of IP-10/CXCR3 promotes progressive renal fibrosis. Nephron Exp Nephrol 2007 0.90
22 Role of Cytokines and Chemokines in Renal Ischemia-Reperfusion Injury. Drug News Perspect 2002 0.89
23 The impacts of albuminuria and low eGFR on the risk of cardiovascular death, all-cause mortality, and renal events in diabetic patients: meta-analysis. PLoS One 2013 0.88
24 Long-term outcomes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy. Diabetes Care 2013 0.88
25 Clinical impact of albuminuria in diabetic nephropathy. Clin Exp Nephrol 2011 0.87
26 Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. BMC Nephrol 2013 0.86
27 A superagonistic monoclonal antibody for CD28 ameliorates crescentic glomerulonephritis in wistar-kyoto rats. Mol Med 2011 0.86
28 Dendritic cells contribute to autoimmune kidney injury in MRL-Faslpr mice. J Rheumatol 2009 0.86
29 Glycoprotein hyposialylation gives rise to a nephrotic-like syndrome that is prevented by sialic acid administration in GNE V572L point-mutant mice. PLoS One 2012 0.86
30 Effect of sevelamer hydrochloride on markers of bone turnover in Japanese dialysis patients with low biointact PTH levels. Intern Med 2007 0.86
31 CD68 and MCP-1/CCR2 expression of initial biopsies reflect the outcomes of membranous nephropathy. Nephron Clin Pract 2004 0.85
32 Cytokine profiles of patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome. Cytokine 2012 0.85
33 Kidney lesions in diabetic patients with normoalbuminuric renal insufficiency. Clin Exp Nephrol 2013 0.84
34 Reduction in chronic allograft nephropathy by inhibition of p38 mitogen-activated protein kinase. Am J Nephrol 2006 0.84
35 Adipose tissue derived stromal stem cell therapy in murine ConA-derived hepatitis is dependent on myeloid-lineage and CD4+ T-cell suppression. Eur J Immunol 2013 0.83
36 Fractalkine and its receptor, CX3CR1, promote hypertensive interstitial fibrosis in the kidney. Hypertens Res 2011 0.83
37 Chemokines in renal fibrosis. Contrib Nephrol 2003 0.83
38 Relapse and its remission in Japanese patients with idiopathic membranous nephropathy. Clin Exp Nephrol 2014 0.83
39 Nodular lesions and mesangiolysis in diabetic nephropathy. Clin Exp Nephrol 2012 0.81
40 Anti-erythropoietin receptor antibody-associated pure red cell aplasia accompanied by Coombs-negative autoimmune hemolytic anemia in a patient with T cell/histiocyte-rich large B cell lymphoma. Int J Hematol 2014 0.78
41 Treatment and impact of dyslipidemia in diabetic nephropathy. Clin Exp Nephrol 2013 0.78
42 Successful treatment of recurrent focal segmental glomerulosclerosis after renal transplantation by lymphocytapheresis and rituximab. Transpl Int 2010 0.78
43 A case of neurosarcoidosis with necrotizing granuloma expressing angiotensin-converting enzyme. Mod Rheumatol 2010 0.78
44 Impact of kidney function and urinary protein excretion on pulmonary function in Japanese patients with chronic kidney disease. Clin Exp Nephrol 2013 0.77
45 The beneficial effects of lymphocytapheresis for treatment of nephrotic syndrome. Ther Apher 2002 0.77
46 Autoantibodies to erythropoietin receptor in patients with immune-mediated diseases: relationship to anaemia with erythroid hypoplasia. Br J Haematol 2012 0.76
47 Long-term observations of clinicopathological characteristics and outcome of Japanese patients with pauci-immune crescentic glomerulonephritis. Clin Exp Nephrol 2013 0.75
48 Significant prolongation of animal survival by combined therapy of FR167653 and cyclosporine A in rat renal allografts. Transplantation 2003 0.75
49 [Points of revision of the guideline JSLM 2012]. Rinsho Byori 2014 0.75
50 [Involvement of myeloid derived immunosuppressive cells in progressive renal diseases]. Nihon Rinsho Meneki Gakkai Kaishi 2013 0.75
51 [Acute kidney injury: progress in diagnosis and treatments. Topics: IV. Pathophysiology and treatments; 3. Drug induced AKI]. Nihon Naika Gakkai Zasshi 2014 0.75
52 [Update information for physicians on laboratory tests: recent progress in clinical laboratory testing. Topics: II. Particulars with special emphasis on novel laboratory tests; 5. Kidney and urinary tract disease]. Nihon Naika Gakkai Zasshi 2011 0.75
53 [Trends for the etiology of infective endocarditis at our hospital these 5 years]. Rinsho Byori 2014 0.75
54 Successful delivery in a patient with antineutrophil cytoplasmic antibody-associated glomerulonephritis. Intern Med 2013 0.75
55 Serum Autotaxin Levels Are Associated with Proteinuria and Kidney Lesions in Japanese Type 2 Diabetic Patients with Biopsy-proven Diabetic Nephropathy. Intern Med 2016 0.75
56 [Impact of dyslipidemia on the onset and progression of diabetic complications]. Nihon Jinzo Gakkai Shi 2013 0.75
57 [Clinical and pathological features of nephrosclerosis]. Nihon Jinzo Gakkai Shi 2016 0.75
58 Electron-dense deposition patterns and the outcomes of idiopathic membranous nephropathy in Japanese. Med Electron Microsc 2002 0.75
59 [Advances in the treatment of progressive renal dysfunctions. 7. Immunosuppressive agents used to treat renal dysfunctions and their indication]. Nihon Naika Gakkai Zasshi 2004 0.75
60 TAK-603, an anti-inflammatory compound, reduces crescentic glomerulonephritis and preserves renal function in WKY rats. Nephrol Dial Transplant 2006 0.75
61 Catastrophic anti-phospholipid syndrome associated with Escherichia coli O157 infection. Rheumatology (Oxford) 2009 0.75
62 [Registry system of diabetic nephropathy in Japan]. Nihon Rinsho 2012 0.75
63 CCL2/CCR2 augments the production of transforming growth factor-beta1, type 1 collagen and CCL2 by human CD45-/collagen 1-positive cells under high glucose concentrations. Clin Exp Nephrol 2013 0.75